WuXi AppTec USA News and Activities

WuXi AppTec USA is owned by HiberCell. HiberCell has a direct presence in 2 countries.

HiberCell has 7 subsidiaries including Genuity Science, STA Pharmaceutical and WuXi AppTec.

They are in:

• Biotechnology88%
• Pharmaceuticals13%

View the org chart displaying its 11 main executives

Most searched biographies at WuXi AppTec USA

• Richard Connell, President
• Jason Castle, Senior Director, Finance and Business Operations
• Peter Xia, Marketing Manager

Create your alert
to follow the executive moves at WuXi AppTec USA.

HiberCell has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by WuXi AppTec USA

Social media about WuXi AppTec USA

• WuXi AppTec USA on Wikipedia, Google News & Yahoo Finance
• WuXi AppTec USA on LinkedIn, X (Twitter) & YouTube